查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1439233

全球電生理設備市場：洞察、競爭格局、市場預測：2030 年

Electrophysiology Devices - Market Insights, Competitive Landscape, and Market Forecast - 2030
出版日期: 按訂單生產 | 出版商: DelveInsight | 英文 150 Pages | 商品交期: 2-10個工作天內

價格

2023年全球電生理設備市場規模為69.2億美元。 預計到 2030 年，該市場將達到 120.8 億美元，2024 年至 2030 年的預測期間複合年增長率為 9.74%。 電生理設備的需求主要是由於心血管疾病盛行率的上升、產品開發的技術進步、老年人口的增加、久坐的生活方式以及對心血管疾病的認識計劃的提高而推動的。

根據世界衛生組織 (WHO) 數據（2023 年），心血管疾病 (CVD) 是全球主要死亡原因，該疾病每年估計奪去 1,790 萬人的生命。 此外，同一世界衛生組織數據顯示，超過五分之四的 CVD 死亡病例以中風和心臟病發作為主要原因，其中三分之一的死亡發生在 70 歲之前。 超過四分之三的心血管疾病死亡發生在低收入和中等收入國家。

根據歐洲心臟學會 (ESC) 數據（2023 年），心血管疾病 (CVD) 每年導致歐洲 390 萬人死亡，歐盟 (EU) 180 萬人死亡，其中死亡人數超過 1,000 人。 它約佔歐洲所有死亡人數的 45%，佔歐盟死亡人數的 37%。

上述事實凸顯了迫切需要採取措施來解決全球日益增加的 CVD 疾病負擔。 動脈硬化、心律不整和心臟衰竭等症狀會嚴重影響患者的生活質量，甚至危及生命。 此外，定期監測心律和活動通常可以降低 CVD 的嚴重程度。 這可以透過引入心電圖監視器和植入式心臟監視器等電生理設備來實現。 這些設備允許醫療保健提供者和患者根據需要監測心臟健康狀況。 此外，先進的電生理程序（例如使用射頻和冷凍消融等各種消融方式進行心臟消融）也提供了治療各種原因的心臟疾病的方法。 因此，隨著全球心血管疾病盛行率的上升，電生理設備市場預計將在預測期內顯著增長。

然而，熟練的專業人員數量有限且嚴格的監管產品審批流程可能是電生理設備市場成長的某些限制因素。

本報告研究了全球電生理學設備市場，並提供了市場概述，包括按設備、模式、應用、最終用戶、地區以及參與市場的公司概況劃分的趨勢。

目錄

第一章電生理設備市場報告簡介

第 2 章電生理設備市場執行摘要

第三章監理分析

  • 美國
  • 歐洲
  • 日本
  • 中國

第四章電生理設備市場主要因素分析

  • 推動電生理學設備市場的因素
  • 電生理設備市場的限制與挑戰
  • 電生理設備市場機遇

第五章波特對電生理設備市場的五力分析

第 6 章電生理設備市場概論

  • 按設備
  • 按方式
  • 依用途
  • 按最終用戶
  • 按地區

第七章電生理設備公司及產品簡介

  • Boston Scientific Corporation
  • Lepu Medical Technology（Beijing）Co. Ltd
  • GENERAL ELECTRIC COMPANY
  • Medtronic
  • Abbott
  • BIOTRONIK
  • Microport Scientific Corporation
  • Acutus Medical inc
  • Imricor
  • Medical Devices Business Services, Inc. (Johnson & Johnson)
  • Baylis Medical Company Inc
  • Schwarzer Cardiotek GmbH
  • ATRICURE, INC
  • CardioFocus
  • Osypka AG

第8章KOL瀏覽量

第 9 章專案方法

第10章DelveInsight服務內容

第 11 章關於 DelveInsight

第 12 章免責聲明與聯絡我們

Product Code: DIMDCL0018

Electrophysiology Devices Market By Device Type (Treatment Devices [Defibrillators, Pacemakers, Cardiac Resynchronization Therapy Devices, Ablation Systems [Radiofrequency, Cryoablation, and Others], and Others], Diagnostic Devices [ECG Monitors [Stress, Rest, and Holter Monitors], Ep X-Ray Systems, Ep Recording Systems, Ep Imaging & Mapping Systems, Implantable Cardiac Monitors, and Others]), Modality (Implantable and External), Application (Ventricular Tachycardia, Atrial Fibrillation, Bradycardia, and Others), End-User (Hospitals, Ambulatory Surgical Centers, and Others), and Geography is expected to grow at a steady CAGR forecast till 2030 owing to Rising Prevalence of Cardiovascular Diseases and Increasing Advancements in Product Development

The global Electrophysiology Devices Market was valued at USD 6.92 billion in 2023, growing at a CAGR of 9.74% during the forecast period from 2024 to 2030, to reach USD 12.08 billion by 2030. The demand for electrophysiology devices is primarily being boosted by the rising prevalence of cardiovascular diseases, technological advancement in product development, increasing geriatric population, sedentary lifestyle, and increasing awareness programs regarding cardiovascular diseases.

Electrophysiology Devices Market Dynamics:

As per data provided by the World Health Organization (2023), cardiovascular diseases (CVDs) are the leading cause of death across the globe, where this group of diseases accounts for an estimated 17.9 million lives each year. Furthermore, the same data by the WHO presented that over four out of five, CVD deaths list strokes and heart attacks as the main cause, and one-third of these deaths are said to occur prematurely in people below 70 years of age. Over three-quarters of CVD deaths take place in low- and middle-income countries.

According to the data provided by the European Society for Cardiology (ESC) (2023), each year cardiovascular disease (CVD) causes 3.9 million deaths in Europe and over 1.8 million deaths in the European Union. They represent about 45% of all deaths in Europe and 37% in the EU.

The above-mentioned facts highlight the dire need for measures to address the rising disease burden of CVDs across the globe. Indications such as atherosclerosis, arrhythmias, and heart failure can severely affect the quality of life of patients and may even prove to be life-threatening. Furthermore, in many cases, the severity of CVDs can be reduced by regular monitoring of cardiac rhythms and activities. This can be achieved by deploying electrophysiology devices such as ECG monitors, and implantable cardiac monitors, among others. These devices enable healthcare providers as well as patients to monitor cardiac health as per the need, i.e. either continuous or periodic monitoring, thereby helping in the improvement of disease prognosis as well helping in early disease diagnosis. Moreover, advanced electrophysiology procedures such as cardiac ablation using different ablation procedures such as radiofrequency and cryoablation also offer a way for treating heart diseases of various etiologies. Therefore, the electrophysiology devices market is expected to witness remarkable growth during the forecast period due to the rising global prevalence of CVDs.

However, the limited availability of skilled professionals and stringent regulatory product approval process may prove to be certain restraints to the electrophysiology devices market growth.

Electrophysiology Devices Market Segment Analysis:

Electrophysiology Devices Market By Device Type (Treatment Devices [Defibrillators, Pacemakers, Cardiac Resynchronization Therapy Devices, Ablation Systems [Radiofrequency, Cryoablation, And Others], And Others], Diagnostic Devices [ECG Monitors [Stress, Rest, And Holter Monitors], EP X-Ray Systems, EP Recording Systems, EP Imaging & Mapping Systems, Implantable Cardiac Monitors, And Others]), Modality (Implantable And External), Application (Ventricular Tachycardia, Atrial Fibrillation, Bradycardia, And Others), End-User (Hospitals, Ambulatory Surgical Centers, And Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World).

In the device type segment, under the diagnostic devices category of the electrophysiology devices market, the ECG monitors segment is expected to amass the largest market share during the forecast period.

ECG systems have been the most commonly used devices for cardiac monitoring. These devices are generally found in hospital setups and have been the conventional and most preferred mode of ECG monitoring of patients. Besides being one of the oldest technologies present, these devices are economical to procure for healthcare facilities, which in turn, makes them an affordable diagnostic procedure for patients.

ECG tests are the preliminary test where cardiac malfunctioning is suspected and where their results become important before proceeding with advanced tests or deciding a treatment approach.

Furthermore, technological advancements and product innovations taking place in the development of ECG devices are likely to propel the electrophysiology devices market growth. For example, in February 2021, Qardio Inc received 510k approval from the US Food and Drug Administration for the QardioCore device, which is an ambulatory ECG monitoring device that can record ECG information for up to 24 hours in a single session.

Hence, owing to the above-mentioned factors the ECG Monitors category is expected to witness growth, thereby propelling the growth of the overall electrophysiology devices market.

North America Is Expected To Dominate The Overall Electrophysiology Devices Market:

Among all the regions, North America is expected to account for the largest share of the electrophysiology devices market. The growing prevalence of cardiovascular diseases such as heart failure and atrial fibrillation, access to better healthcare infrastructure along with the presence of major market players in the region are predicted to be the major influencing factors in driving the overall growth of the electrophysiology devices market over the forecast period.

As per the facts provided by the Centers for Disease Prevention and Control (CDC), heart disease is the leading cause of death for men, women, and people of most racial and ethnic groups in the United States where about 655,000 Americans die from heart disease each year.

As per the data provided by the National Center for Health Statistics, a part of the CDC, in 2018, atrial fibrillation was mentioned as the cause of death in 25,845 deaths and was in the United States. It further stated that approximately 12.1 million people in the United States will have AFib in 2030.

Additionally, a Report by the American Heart Association providing data for 2020 mentioned that nearly about 6.2 million adults in the United States have heart failure. The statistics for 2019 by the same organization stated that in 2018, heart failure was mentioned on 379,800 death certificates in the country. As electrophysiology devices have a major application in detecting heart failure Afib, the increasing number of AFib and heart failure patients in the country is expected to drive the market over the forecast period.

The well-established healthcare infrastructure in the country with supportive reimbursement programs covering the costs for the electrophysiology procedures as well as the treatment devices further encourages people to opt for such procedures and devices.

In June 2021, Medtronic received expanded approval from the US Food and Drug Administration (FDA) for its Arctic Front Family of Cardiac Cryoablation Catheters for the treatment of recurrent symptomatic paroxysmal atrial fibrillation (AF).

In June 2020, Boston Scientific Corporation received 510k approval from the US Food and Drug Administration for the LUX-Dx(TM) Insertable Cardiac Monitor (ICM) System which is a long-term implantable diagnostic device for the detection of arrhythmias associated with conditions such as cryptogenic stroke, atrial fibrillation (AF), and syncope.

Considering the presence of a large patient pool in the US coupled with new product launches, the market for electrophysiology devices looks promising in the United States.

Electrophysiology Devices Market Key Players:

Some of the key market players operating in the electrophysiology devices market include Boston Scientific Corporation, Lepu Medical Technology (Beijing) Co. Ltd, GENERAL ELECTRIC COMPANY, Medtronic, Abbott, BIOTRONIK, Microport Scientific Corporation, Acutus Medical, Inc., Imricor, Medical Devices Business Services, Inc. (Johnson & Johnson), Baylis Medical Company, Inc, Schwarzer Cardiotek GmbH, ATRICURE, INC., CardioFocus, Osypyka AG and others.

Recent Developmental Activities in Electrophysiology Devices Market:

In December 2020, Acutus Medical Inc announced the launch of their AcQBlate® Force Sensing Ablation System in Europe after securing the CE Mark for the company's AcQBlate FORCE ablation catheter and the Qubic Force Sensing Module (Qubic Force).

In November 2020, Abbott received the CE mark and Approval from the Australian Regulatory Authority for their EnSite(TM) X EP System, which is equipped with advanced imaging capabilities and allows for the creation of a 3D model of the cardiac anatomy of patients. This system is developed to offer electrophysiologists a smoother platform to help deliver ablation therapy to treat abnormal heart rhythms.

In January 2020, Imricor received CE mark approval for its Vision-MR Ablation Catheter and Vision-MR Dispersive Electrode. This is the first and only company to offer cardiac ablation devices for use in the MRI environment.

Key Takeaways from the Electrophysiology Devices Market Report Study

Market size analysis for current market size (2023), and market forecast for 5 years (2024-2030)

The effect of the COVID-19 pandemic on this market is significant. To capture and analyze suitable indicators, our experts are closely watching the electrophysiology devices market.

Top key product/services/technology developments, mergers, acquisitions, partnerships, and joint ventures happened for the last 3 years

Key companies dominating the Global Electrophysiology Devices Market.

Various opportunities are available for the other competitor in the Electrophysiology Devices Market space.

What are the top-performing segments in 2023? How these segments will perform in 2030?

Which are the top-performing regions and countries in the current electrophysiology devices market scenario?

Which are the regions and countries where companies should have concentrated on opportunities for electrophysiology devices market growth in the coming future?

Target Audience who can be benefited from this Electrophysiology Devices Market Report Study

Electrophysiology device products providers

Research organizations and consulting companies

Electrophysiology Devices-related organization, association, forum, and other alliances

Government and corporate offices

Start-up companies, venture capitalists, and private equity firms

Distributors and Traders dealing in electrophysiology devices

Various End-users who want to know more about the Electrophysiology Devices market and the latest technological developments in the Electrophysiology Devices market.

Frequently Asked Questions for Electrophysiology Devices Market:

What is an Electrophysiology Device?

An electrophysiology device helps in the assessment of the electrical activity of the heart. These devices help in the diagnosis as well as in the treatment of diseases related to the electrical system of the heart.

What is the market for Global Electrophysiology Devices?

Global Electrophysiology Devices Market was valued at USD 6.92 billion in 2023, growing at a CAGR of 9.74% during the forecast period from 2024 to 2030, to reach USD 12.08 billion by 2030.

What are the drivers for Global Electrophysiology Devices Market?

The major drivers of the global electrophysiology devices market are the rising cardiovascular disease prevalence, technological advancement in product development, increasing geriatric population, sedentary lifestyle, and increasing focus on making people aware of cardiovascular diseases.

What are the key players operating in Global Electrophysiology Devices Market?

Some of the major players operating in the electrophysiology devices market include Boston Scientific Corporation, Lepu Medical Technology (Beijing) Co. Ltd, GENERAL ELECTRIC COMPANY, Medtronic, Abbott, BIOTRONIK, Microport Scientific Corporation, Acutus Medical, Inc., Imricor, Medical Devices Business Services, Inc. (Johnson & Johnson), Baylis Medical Company, Inc, Schwarzer Cardiotek GmbH, ATRICURE, INC., CardioFocus, Osypyka AG and others.

What region has the highest share in the Electrophysiology Devices market?

North America is expected to account for the largest revenue share in the overall electrophysiology devices market during the forecast period, 2024 to 2030. This high growth in the market can be attributed to the increasing prevalence of cardiovascular diseases such as atrial fibrillation and heart failure and encouraging reimbursement policies in the region, especially in the US.

Table of Contents

1. Electrophysiology Devices Market Report Introduction

2. Electrophysiology Devices Market Executive Summary

  • 2.1. Scope of the Study
  • 2.2. Market at Glance
  • 2.3. Competitive Assessment

3. Regulatory Analysis

  • 3.1. The United States
  • 3.2. Europe
  • 3.3. Japan
  • 3.4. China

4. Electrophysiology Devices Market Key Factors Analysis

  • 4.1. Electrophysiology Devices Market Drivers
    • 4.1.1. Increasing Prevalence of Cardiovascular Diseases
    • 4.1.2. Rising Sedentary Lifestyle
    • 4.1.3. Increasing Geriatric Population
    • 4.1.4. Increasing Awareness Programs Regarding Cardiovascular Diseases
  • 4.2. Electrophysiology Devices Market Restraints and Challenges
    • 4.2.1. Limited availability of skilled professionals
    • 4.2.2. Stringent Regulatory Product Approval Process
  • 4.3. Electrophysiology Devices Market Opportunities
    • 4.3.1. Improving Product Safety
    • 4.3.2. Targeting Emerging Markets for Product Launches

5. Electrophysiology Devices Market Porter's Five Forces Analysis

  • 5.1. Bargaining Power of Suppliers
  • 5.2. Bargaining Power of Consumers
  • 5.3. Threat of New Entrants
  • 5.4. Threat of Substitutes
  • 5.5. Competitive Rivalry

6. Electrophysiology Devices Market Layout

  • 6.1. By Devices
    • 6.1.1. Treatment Devices
      • 6.1.1.1. Defibrillators
      • 6.1.1.2. Pacemakers
      • 6.1.1.3. Cardiac Resynchronization Therapy Devices
      • 6.1.1.4. Ablation Systems
      • 6.1.1.4.1. Radiofrequency
      • 6.1.1.4.2. Cryoablation
      • 6.1.1.4.3. Others
      • 6.1.1.5. Others
    • 6.1.2. Diagnostic Devices
      • 6.1.2.1. ECG Monitors
      • 6.1.2.1.1. Stress
      • 6.1.2.1.2. Rest
      • 6.1.2.1.3. Holter Monitors
      • 6.1.2.2. EP X-Ray Systems
      • 6.1.2.3. EP Recording Systems
      • 6.1.2.4. EP Imaging & Mapping Systems
      • 6.1.2.5. Implantable Cardiac Monitors
      • 6.1.2.6. Others
  • 6.2. By Modality
    • 6.2.1. Implantable
    • 6.2.2. External
  • 6.3. By Application
    • 6.3.1. Ventricular Tachycardia
    • 6.3.2. Atrial Fibrillation
    • 6.3.3. Bradycardia
    • 6.3.4. Others
  • 6.4. By End-User
    • 6.4.1. Hospitals
    • 6.4.2. Ambulatory Surgical Centers
    • 6.4.3. Others
  • 6.5. By Geography
    • 6.5.1. North America Electrophysiology Devices Market in USD million (2021-2030)
      • 6.5.1.1. United States Electrophysiology Devices Market in USD million (2021-2030)
      • 6.5.1.2. Canada Electrophysiology Devices Market in USD million (2021-2030)
      • 6.5.1.3. Mexico Electrophysiology Devices Market in USD million (2021-2030)
    • 6.5.2. Europe Electrophysiology Devices Market in USD million (2021-2030)
      • 6.5.2.1. France Electrophysiology Devices Market in USD million (2021-2030)
      • 6.5.2.2. Germany Electrophysiology Devices Market in USD million (2021-2030)
      • 6.5.2.3. United Kingdom Electrophysiology Devices Market in USD million (2021-2030)
      • 6.5.2.4. Italy Electrophysiology Devices Market in USD million (2021-2030)
      • 6.5.2.5. Spain Electrophysiology Devices Market in USD million (2021-2030)
      • 6.5.2.6. Rest of Europe Electrophysiology Devices Market in USD million (2021-2030)
    • 6.5.3. Asia-Pacific Electrophysiology Devices Market in USD million (2021-2030)
      • 6.5.3.1. China Electrophysiology Devices Market in USD million (2021-2030)
      • 6.5.3.2. Japan Electrophysiology Devices Market in USD million (2021-2030)
      • 6.5.3.3. India Electrophysiology Devices Market in USD million (2021-2030)
      • 6.5.3.4. Australia Electrophysiology Devices Market in USD million (2021-2030)
      • 6.5.3.5. South Korea Electrophysiology Devices Market in USD million (2021-2030)
      • 6.5.3.6. Rest of Asia-Pacific Electrophysiology Devices Market in USD million (2021-2030)
    • 6.5.4. Rest of the World (RoW) Electrophysiology Devices Market in USD million (2021-2030)
      • 6.5.4.1. Middle East Electrophysiology Devices Market in USD million (2021-2030)
      • 6.5.4.2. Africa Electrophysiology Devices Market in USD million (2021-2030)
      • 6.5.4.3. South America Electrophysiology Devices Market in USD million (2021-2030)

7. Electrophysiology Devices Company and Product Profiles

  • 7.1. Boston Scientific Corporation
    • 7.1.1. Company Overview
    • 7.1.2. Company Snapshot
    • 7.1.3. Financial Overview
    • 7.1.4. Product Listing
    • 7.1.5. Entropy
  • 7.2. Lepu Medical Technology (Beijing) Co. Ltd
    • 7.2.1. Company Overview
    • 7.2.2. Company Snapshot
    • 7.2.3. Financial Overview
    • 7.2.4. Product Listing
    • 7.2.5. Entropy
  • 7.3. GENERAL ELECTRIC COMPANY
    • 7.3.1. Company Overview
    • 7.3.2. Company Snapshot
    • 7.3.3. Financial Overview
    • 7.3.4. Product Listing
    • 7.3.5. Entropy
  • 7.4. Medtronic
    • 7.4.1. Company Overview
    • 7.4.2. Company Snapshot
    • 7.4.3. Financial Overview
    • 7.4.4. Product Listing
    • 7.4.5. Entropy
  • 7.5. Abbott
    • 7.5.1. Company Overview
    • 7.5.2. Company Snapshot
    • 7.5.3. Financial Overview
    • 7.5.4. Product Listing
    • 7.5.5. Entropy
  • 7.6. BIOTRONIK
    • 7.6.1. Company Overview
    • 7.6.2. Company Snapshot
    • 7.6.3. Financial Overview
    • 7.6.4. Product Listing
    • 7.6.5. Entropy
  • 7.7. Microport Scientific Corporation
    • 7.7.1. Company Overview
    • 7.7.2. Company Snapshot
    • 7.7.3. Financial Overview
    • 7.7.4. Product Listing
    • 7.7.5. Entropy
  • 7.8. Acutus Medical inc
    • 7.8.1. Company Overview
    • 7.8.2. Company Snapshot
    • 7.8.3. Financial Overview
    • 7.8.4. Product Listing
    • 7.8.5. Entropy
  • 7.9. Imricor
    • 7.9.1. Company Overview
    • 7.9.2. Company Snapshot
    • 7.9.3. Financial Overview
    • 7.9.4. Product Listing
    • 7.9.5. Entropy
  • 7.10. Medical Devices Business Services, Inc. (Johnson & Johnson)
    • 7.10.1. Company Overview
    • 7.10.2. Company Snapshot
    • 7.10.3. Financial Overview
    • 7.10.4. Product Listing
    • 7.10.5. Entropy
  • 7.11. Baylis Medical Company Inc
    • 7.11.1. Company Overview
    • 7.11.2. Company Snapshot
    • 7.11.3. Financial Overview
    • 7.11.4. Product Listing
    • 7.11.5. Entropy
  • 7.12. Schwarzer Cardiotek GmbH
    • 7.12.1. Company Overview
    • 7.12.2. Company Snapshot
    • 7.12.3. Financial Overview
    • 7.12.4. Product Listing
    • 7.12.5. Entropy
  • 7.13. ATRICURE, INC
    • 7.13.1. Company Overview
    • 7.13.2. Company Snapshot
    • 7.13.3. Financial Overview
    • 7.13.4. Product Listing
    • 7.13.5. Entropy
  • 7.14. CardioFocus
    • 7.14.1. Company Overview
    • 7.14.2. Company Snapshot
    • 7.14.3. Financial Overview
    • 7.14.4. Product Listing
    • 7.14.5. Entropy
  • 7.15. Osypka AG
    • 7.15.1. Company Overview
    • 7.15.2. Company Snapshot
    • 7.15.3. Financial Overview
    • 7.15.4. Product Listing
    • 7.15.5. Entropy

8. KOL Views

9. Project Approach

10. DelveInsight Capabilities

11. About DelveInsight

12. Disclaimer & Contact Us

List of Tables

  • Table 1: Competitive Analysis
  • Table 2: Electrophysiology Devices Market in Global (2021-2030)
  • Table 3: Electrophysiology Devices Market in Global by Device Type (2021-2030)
  • Table 4: Electrophysiology Devices Market in Global by Modality (2021-2030)
  • Table 5: Electrophysiology Devices Market in Global by Application (2021-2030)
  • Table 6: Electrophysiology Devices Market in Global by End-User (2021-2030)
  • Table 7: Electrophysiology Devices Market in Global by Geography (2021-2030)
  • Table 8: Electrophysiology Devices Market in North America (2021-2030)
  • Table 9: Electrophysiology Devices Market in the US (2021-2030)
  • Table 10: Electrophysiology Devices Market in Canada (2021-2030)
  • Table 11: Electrophysiology Devices Market in Mexico (2021-2030)
  • Table 12: Electrophysiology Devices Market in Europe (2021-2030)
  • Table 13: Electrophysiology Devices Market in France (2021-2030)
  • Table 14: Electrophysiology Devices Market in Germany (2021-2030)
  • Table 15: Electrophysiology Devices Market in the United Kingdom (2021-2030)
  • Table 16: Electrophysiology Devices Market in Italy (2021-2030)
  • Table 17: Electrophysiology Devices Market in Spain (2021-2030)
  • Table 18: Electrophysiology Devices Market in Rest of Europe (2021-2030)
  • Table 19: Electrophysiology Devices Market in APAC (2021-2030)
  • Table 20: Electrophysiology Devices Market in China (2021-2030)
  • Table 21: Electrophysiology Devices Market in Japan (2021-2030)
  • Table 22: Electrophysiology Devices Market in India (2021-2030)
  • Table 23: Electrophysiology Devices Market in Australia (2021-2030)
  • Table 24: Electrophysiology Devices Market in South Korea (2021-2030)
  • Table 25: Electrophysiology Devices Market in Rest of APAC (2021-2030)
  • Table 26: Electrophysiology Devices Market in the Rest of the World (2021-2030)
  • Table 27: Electrophysiology Devices Market in the Middle East (2021-2030)
  • Table 28: Electrophysiology Devices Market in Africa (2021-2030)
  • Table 29: Electrophysiology Devices Market in South America (2021-2030)

List of Figures

  • Figure 1: Competitive Analysis
  • Figure 2: Electrophysiology Devices Market in Global (2021-2030)
  • Figure 3: Electrophysiology Devices Market in Global by Device Type (2021-2030)
  • Figure 4: Electrophysiology Devices Market in Global by Modality (2021-2030)
  • Figure 5: Electrophysiology Devices Market in Global by Application (2021-2030)
  • Figure 6: Electrophysiology Devices Market in Global by End-User (2021-2030)
  • Figure 7: Electrophysiology Devices Market in Global by Geography (2021-2030)
  • Figure 8: Electrophysiology Devices Market in North America (2021-2030)
  • Figure 9: Electrophysiology Devices Market in the US (2021-2030)
  • Figure 10: Electrophysiology Devices Market in Canada (2021-2030)
  • Figure 11: Electrophysiology Devices Market in Mexico (2021-2030)
  • Figure 12: Electrophysiology Devices Market in Europe (2021-2030)
  • Figure 13: Electrophysiology Devices Market in France (2021-2030)
  • Figure 14: Electrophysiology Devices Market in Germany (2021-2030)
  • Figure 15: Electrophysiology Devices Market in the United Kingdom (2021-2030)
  • Figure 16: Electrophysiology Devices Market in Italy (2021-2030)
  • Figure 17: Electrophysiology Devices Market in Spain (2021-2030)
  • Figure 18: Electrophysiology Devices Market in Rest of Europe (2021-2030)
  • Figure 19: Electrophysiology Devices Market in APAC (2021-2030)
  • Figure 20: Electrophysiology Devices Market in China (2021-2030)
  • Figure 21: Electrophysiology Devices Market in Japan (2021-2030)
  • Figure 22: Electrophysiology Devices Market in India (2021-2030)
  • Figure 23: Electrophysiology Devices Market in Australia (2021-2030)
  • Figure 24: Electrophysiology Devices Market in South Korea (2021-2030)
  • Figure 25: Electrophysiology Devices Market in Rest of APAC (2021-2030)
  • Figure 26: Electrophysiology Devices Market in the Rest of the World (2021-2030)
  • Figure 27: Electrophysiology Devices Market in the Middle East (2021-2030)
  • Figure 28: Electrophysiology Devices Market in Africa (2021-2030)
  • Figure 29: Electrophysiology Devices Market in South America (2021-2030)
  • Figure 30: Market Drivers
  • Figure 31: Market Barriers
  • Figure 32: Marker Opportunities
  • Figure 33: PORTER'S Five Force Analysis